

Research
Research on microdosing psychedelics remains in the early-stage. Having only been around as a methodology for the past ten years, microdosing research is far behind that of psychedelic-assisted psychotherapy research. Common themes currently being explored in research include treatment for clinical conditions, like depression and ADHD, as well as performance based measures like focus and creativity.
Recent Articles
-
Global Drug Survey points to an increase in ‘microdosing’ psychedelics for wellbeing
-
As Silicon Valley and the far-right embrace microdosing, can psychedelics really heal the world?
-
More People Are Microdosing for Mental Health. But Does It Work?
-
Oregon Voters Legalized Psilocybin Use. But What About Microdosing?
Cloud Analytics Modernization
Cloud Analytics Modernization

History of Microdosing
Cloud Analytics Modernization
Microdosing LSD

Cloud Analytics Modernization
Microdosing Psilocybin

Cloud Analytics Modernization
Microdosing Cannabis
Cloud Analytics Modernization
Microdosing to Improve Mental Health
Non-Clinical Microdosing Studies
-
Microdosing Psychedelics: Personality, Mental Health, and Creativity Differences in Microdosers
-
Exploring The Effect of Microdosing Psychedelics on Creativity in an Open-Label Natural Setting
-
Psilocybin with Psychological Support for Treatment-Resistant Depression: Six-Month Follow-Up
-
Psilocybin for Treatment-Resistant Depression: fMRI-Measured Brain Mechanisms
-
Powerful Substances in Tiny Amounts: An Interview Study of Psychedelic Microdosing